Related Articles
An elderly patient with DCIS of the breast effectively treated with toremifene alone
High-dose toremifene as first-line treatment of metastatic breast cancer resistant to adjuvant aromatase inhibitor: A multicenter phase II study
Toremifene-induced fatty liver and NASH in breast cancer patients with breast-conservation treatment.
Breast-conservation treatment for bilateral breast cancer in five Japanese women
Down-regulation of nitric oxide production by droloxifene and toremifene in human breast cancer cells